These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7855464)

  • 1. A direct, general approach based on isobolograms for assessing the joint action of drugs in pre-clinical experiments.
    Machado SG; Robinson GA
    Stat Med; 1994 Nov; 13(22):2289-309. PubMed ID: 7855464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of synergistic response to combinations containing AZT in AZT-resistant HIV-1.
    Cox SW; Albert J; Wahlberg J; Uhlén M; Wahren B
    AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1229-34. PubMed ID: 1520536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
    Periclou AP; Nandy P; Avramis VI
    In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro analysis of synergism and antagonism of different nucleoside/nucleotide analogue combinations on the inhibition of human immunodeficiency virus type 1 replication.
    Perez-Olmeda M; Garcia-Perez J; Mateos E; Spijkers S; Ayerbe MC; Carcas A; Alcami J
    J Med Virol; 2009 Feb; 81(2):211-6. PubMed ID: 19107982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A flexible unified approach to the analysis of pre-clinical combination studies.
    Harbron C
    Stat Med; 2010 Jul; 29(16):1746-56. PubMed ID: 20572122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of nucleoside-resistant variants of HIV-1 by in vitro selection in the presence of AZT or DDI but no by combinations.
    Gao Q; Parniak MA; Gu Z; Wainberg MA
    Leukemia; 1992; 6 Suppl 3():192S-195S. PubMed ID: 1602823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life.
    Kovacs A; Cowles MK; Britto P; Capparelli E; Fowler MG; Moye J; McIntosh K; Rathore MH; Pitt J; Husson RN
    Pediatr Infect Dis J; 2005 Jun; 24(6):503-9. PubMed ID: 15933559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Didanosine, interferon-alfa and ribavirin: a highly synergistic combination with potential activity against HIV-1 and hepatitis C virus.
    Klein MB; Campeol N; Lalonde RG; Brenner B; Wainberg MA
    AIDS; 2003 May; 17(7):1001-8. PubMed ID: 12700449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of drug combination analysis with isobolograms.
    Tallarida RJ
    J Pharmacol Exp Ther; 2006 Oct; 319(1):1-7. PubMed ID: 16670349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro.
    Larder BA; Kellam P; Kemp SD
    Nature; 1993 Sep; 365(6445):451-3. PubMed ID: 7692302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of multiple drug resistance by sequential in vitro passage of the human immunodeficiency virus type 1.
    Gao Q; Gu Z; Salomon H; Nagai K; Parniak MA; Wainberg MA
    Arch Virol; 1994; 136(1-2):111-22. PubMed ID: 8002779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is resistance of human immunodeficiency viruses (HIV) to nucleoside analogs an indication for their combined use?].
    Pépin JM; Simon F; Brun-Vezinet F
    Pathol Biol (Paris); 1993 Oct; 41(8 Pt 2):788-93. PubMed ID: 8309722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A checkerboard method to evaluate interactions between drugs.
    Martinez-Irujo JJ; Villahermosa ML; Alberdi E; Santiago E
    Biochem Pharmacol; 1996 Mar; 51(5):635-44. PubMed ID: 8615900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic evaluation of drug interactions with anti-HIV drugs, II: Effect of 2',3'-dideoxyinosine (ddI) on zidovudine kinetics in monkeys.
    Gallo JM; Finco TS; Swagler AR; Mehta MU; Viswanathan CT; Qian M
    AIDS Res Hum Retroviruses; 1992 Feb; 8(2):277-83. PubMed ID: 1540413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting the isobole and related quantitative methods for assessing drug synergism.
    Tallarida RJ
    J Pharmacol Exp Ther; 2012 Jul; 342(1):2-8. PubMed ID: 22511201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger.
    Meng Q; Su T; O'Neill JP; Walker VE
    Environ Mol Mutagen; 2002; 39(4):282-95. PubMed ID: 12112380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased hematopoietic toxicity following administration of interferon-a with combination dideoxynucleoside therapy (zidovudine plus ddI) administered in normal mice.
    Gallicchio VS; Scott KW; Hughes NK; Tse KF; Gaines H; Kirk PR; Birch NJ
    Life Sci; 1995; 56(3):PL71-81. PubMed ID: 7823768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Communicating synergism in drug combination studies.
    Brodkin J; Shannon HE
    Arzneimittelforschung; 2000 Aug; 50(8):765-7. PubMed ID: 10994162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro selection and phenotyping of HIV-1 mutants resistant to azidothymidine and didanosine].
    Kiseleva IaIu; Pliasunova OA; Pokrovskaia NV; Pokrovskiĭ AG
    Antibiot Khimioter; 2005; 50(5-6):11-6. PubMed ID: 16526603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug combinations and effect parameters of zidovudine, stavudine, and nevirapine in standardized drug-sensitive and resistant HIV type 1 strains.
    Zhu QY; Scarborough A; Polsky B; Chou TC
    AIDS Res Hum Retroviruses; 1996 Apr; 12(6):507-17. PubMed ID: 8679306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.